Caffeine Use in Neonates: Indications, Pharmacokinetics, Clinical Effects, Outcomes

Abstract

Caffeine is commonly prescribed in the NICU to treat apnea of prematurity. This review is an update based on current knowledge of the mechanisms of action, pharmacologic properties, clinical effects, and safety of caffeine in the neonatal population. Recent studies of caffeine in the neonatal population confirm its efficacy in treating apnea-related… (More)

Topics

2 Figures and Tables

Cite this paper

@inproceedings{Dobson2013CaffeineUI, title={Caffeine Use in Neonates: Indications, Pharmacokinetics, Clinical Effects, Outcomes}, author={Nicole R. Dobson and Carl E. Hunt}, year={2013} }